Liu, Yao-Chung <br/><br/>
Prognostic factors and treatment efficacy in patients with primary diffuse large B-cell lymphoma of the bone: single institute experience over 11 years.  [electronic resource] 

 -  Internal medicine (Tokyo, Japan)  2014 
 - 95-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1349-7235 
<br/><br/><label>Standard No.: </label>10.2169/internalmedicine.53.0967  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Hospitals, General--statistics & numerical data<br/>Hospitals, Veterans--statistics & numerical data<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Positron-Emission Tomography<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Radiotherapy, Adjuvant<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Taiwan--epidemiology<br/>Treatment Outcome<br/>Vincristine--administration & dosage<br/>Young Adult